Glycogen storage disease type III history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  
==Overview==
==Overview==
The majority of patients with [disease name] are asymptomatic.
The hallmark of glycogen storage disease type 3 is hepatomegaly. The most common symptoms of glycogen storage disease include [[abdominal]] protuberance and [[muscle weakness]].
 
OR
 
The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].


==History and Symptoms==
==History and Symptoms==
*The hallmark of glycogen storage disease type 3 is hepatomegaly. The most common symptoms of glycogen storage disease include [[abdominal]] protuberance and muscle weakness.
*The hallmark of glycogen storage disease type 3 is hepatomegaly. The most common symptoms of glycogen storage disease include [[abdominal]] protuberance and [[muscle weakness]].
===History===
===History===
Patients with glycogen storage disease type 3 may have a positive history of:
Patients with glycogen storage disease type 3 may have a positive history of:<ref name="KishnaniAustin2010">{{cite journal|last1=Kishnani|first1=Priya S|last2=Austin|first2=Stephanie L|last3=Arn|first3=Pamela|last4=Bali|first4=Deeksha S|last5=Boney|first5=Anne|last6=Case|first6=Laura E|last7=Chung|first7=Wendy K|last8=Desai|first8=Dev M|last9=El-Gharbawy|first9=Areeg|last10=Haller|first10=Ronald|last11=Smit|first11=G Peter A|last12=Smith|first12=Alastair D|last13=Hobson-Webb|first13=Lisa D|last14=Wechsler|first14=Stephanie Burns|last15=Weinstein|first15=David A|last16=Watson|first16=Michael S|title=Glycogen Storage Disease Type III diagnosis and management guidelines|journal=Genetics in Medicine|volume=12|issue=7|year=2010|pages=446–463|issn=1098-3600|doi=10.1097/GIM.0b013e3181e655b6}}</ref><ref>Dagli A, Sentner CP, Weinstein DA. Glycogen Storage Disease Type III. 2010 Mar 9 [Updated 2016 Dec 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK26372/</ref>
*[[Seizures]] or other manifestations of severe fasting [[hypoglycemia]]
*[[Seizures]] or other manifestations of severe fasting [[hypoglycemia]]
*[[Hepatomegaly]] with [[abdominal]] protuberance
*[[Hepatomegaly]] with [[abdominal]] protuberance
Line 19: Line 15:


===Common Symptoms===
===Common Symptoms===
Common symptoms of glycogen storage disease type 3 include:
Common symptoms of glycogen storage disease type 3 include:<ref name="KishnaniAustin2010">{{cite journal|last1=Kishnani|first1=Priya S|last2=Austin|first2=Stephanie L|last3=Arn|first3=Pamela|last4=Bali|first4=Deeksha S|last5=Boney|first5=Anne|last6=Case|first6=Laura E|last7=Chung|first7=Wendy K|last8=Desai|first8=Dev M|last9=El-Gharbawy|first9=Areeg|last10=Haller|first10=Ronald|last11=Smit|first11=G Peter A|last12=Smith|first12=Alastair D|last13=Hobson-Webb|first13=Lisa D|last14=Wechsler|first14=Stephanie Burns|last15=Weinstein|first15=David A|last16=Watson|first16=Michael S|title=Glycogen Storage Disease Type III diagnosis and management guidelines|journal=Genetics in Medicine|volume=12|issue=7|year=2010|pages=446–463|issn=1098-3600|doi=10.1097/GIM.0b013e3181e655b6}}</ref>
*Protruded abdomen due to hepatomegaly
*Protruded abdomen due to hepatomegaly
*Muscle weakness
*Muscle weakness
Line 27: Line 23:


===Less Common Symptoms===
===Less Common Symptoms===
Less common symptoms of glycogen storage disease type 3 include  
Less common symptoms of glycogen storage disease type 3 include:<ref name="KishnaniAustin2010">{{cite journal|last1=Kishnani|first1=Priya S|last2=Austin|first2=Stephanie L|last3=Arn|first3=Pamela|last4=Bali|first4=Deeksha S|last5=Boney|first5=Anne|last6=Case|first6=Laura E|last7=Chung|first7=Wendy K|last8=Desai|first8=Dev M|last9=El-Gharbawy|first9=Areeg|last10=Haller|first10=Ronald|last11=Smit|first11=G Peter A|last12=Smith|first12=Alastair D|last13=Hobson-Webb|first13=Lisa D|last14=Wechsler|first14=Stephanie Burns|last15=Weinstein|first15=David A|last16=Watson|first16=Michael S|title=Glycogen Storage Disease Type III diagnosis and management guidelines|journal=Genetics in Medicine|volume=12|issue=7|year=2010|pages=446–463|issn=1098-3600|doi=10.1097/GIM.0b013e3181e655b6}}</ref>
*Associated peripheral neuropathy
*Associated peripheral neuropathy
*Symptoms due to polycystic ovary disease
*Symptoms due to polycystic ovary disease

Revision as of 17:27, 22 December 2017

Glycogen storage disease type III Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glycogen storage disease type III from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Glycogen storage disease type III history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glycogen storage disease type III history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glycogen storage disease type III history and symptoms

CDC on Glycogen storage disease type III history and symptoms

Glycogen storage disease type III history and symptoms in the news

Blogs on Glycogen storage disease type III history and symptoms

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Glycogen storage disease type III history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The hallmark of glycogen storage disease type 3 is hepatomegaly. The most common symptoms of glycogen storage disease include abdominal protuberance and muscle weakness.

History and Symptoms

  • The hallmark of glycogen storage disease type 3 is hepatomegaly. The most common symptoms of glycogen storage disease include abdominal protuberance and muscle weakness.

History

Patients with glycogen storage disease type 3 may have a positive history of:[1][2]

Common Symptoms

Common symptoms of glycogen storage disease type 3 include:[1]

  • Protruded abdomen due to hepatomegaly
  • Muscle weakness
  • Hypotonia
  • Wasting of skeletal muscle
  • Symptoms due to cardiac involvement

Less Common Symptoms

Less common symptoms of glycogen storage disease type 3 include:[1]

  • Associated peripheral neuropathy
  • Symptoms due to polycystic ovary disease
  • Ketoacidosis
  • hyperlipidemia
  • Growth retardation

References

  1. 1.0 1.1 1.2 Kishnani, Priya S; Austin, Stephanie L; Arn, Pamela; Bali, Deeksha S; Boney, Anne; Case, Laura E; Chung, Wendy K; Desai, Dev M; El-Gharbawy, Areeg; Haller, Ronald; Smit, G Peter A; Smith, Alastair D; Hobson-Webb, Lisa D; Wechsler, Stephanie Burns; Weinstein, David A; Watson, Michael S (2010). "Glycogen Storage Disease Type III diagnosis and management guidelines". Genetics in Medicine. 12 (7): 446–463. doi:10.1097/GIM.0b013e3181e655b6. ISSN 1098-3600.
  2. Dagli A, Sentner CP, Weinstein DA. Glycogen Storage Disease Type III. 2010 Mar 9 [Updated 2016 Dec 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK26372/

Template:WH Template:WS